Literature DB >> 7489352

The dark side of glucose.

A M Schmidt1, S D Yan, D M Stern.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7489352     DOI： 10.1038/nm1095-1002

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  26 in total

Review 1.  [Non-enzymatic glycation and oxidative stress in chronic illnesses and diabetes mellitus].

Authors:  P P Nawroth; A Bierhaus; G E Vogel; M A Hofmann; M Zumbach; P Wahl; R Ziegler
Journal:  Med Klin (Munich)       Date:  1999-01-15

Review 2.  The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses.

Authors:  A M Schmidt; S D Yan; S F Yan; D M Stern
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

3.  Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response.

Authors:  Birgit Liliensiek; Markus A Weigand; Angelika Bierhaus; Werner Nicklas; Michael Kasper; Stefan Hofer; Jens Plachky; Herman-Josef Gröne; Florian C Kurschus; Ann Marie Schmidt; Shi Du Yan; Eike Martin; Erwin Schleicher; David M Stern; G ünterJ Hämmerling G; Peter P Nawroth; Bernd Arnold
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

4.  An explorative analysis of secretory receptor for advanced glycation endproducts in primary focal segmental glomerulosclerosis.

Authors:  Harin Rhee; Sang Heon Song; Ihm Soo Kwak; Il Young Kim; Eun Young Seong; Dong Won Lee; Soo Bong Lee
Journal:  Clin Exp Nephrol       Date:  2012-08       Impact factor: 2.801

5.  The effects of the receptor for advanced glycation end products (RAGE) on bone metabolism under physiological and diabetic conditions.

Authors:  Yasuhiro Hamada; Sohei Kitazawa; Riko Kitazawa; Keiji Kono; Shunsuke Goto; Hirotaka Komaba; Hideki Fujii; Yasuhiko Yamamoto; Hiroshi Yamamoto; Makoto Usami; Masafumi Fukagawa
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

6.  Decreased levels of soluble receptor for advanced glycation end products in patients with primary Sjögren's syndrome.

Authors:  Carol Stewart; Seunghee Cha; Robert M Caudle; Kathleen Berg; Joseph Katz
Journal:  Rheumatol Int       Date:  2008-01-30       Impact factor: 2.631

7.  Ager Deletion Enhances Ischemic Muscle Inflammation, Angiogenesis, and Blood Flow Recovery in Diabetic Mice.

Authors:  Raquel López-Díez; Xiaoping Shen; Gurdip Daffu; Md Khursheed; Jiyuan Hu; Fei Song; Rosa Rosario; Yunlu Xu; Qing Li; Xiangmei Xi; Yu Shan Zou; Huilin Li; Ann Marie Schmidt; Shi Fang Yan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-06-22       Impact factor: 8.311

8.  Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice.

Authors:  E Lalla; I B Lamster; M Feit; L Huang; A Spessot; W Qu; T Kislinger; Y Lu; D M Stern; A M Schmidt
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

9.  Acute hyperglycemic exacerbation of lung ischemia-reperfusion injury is mediated by receptor for advanced glycation end-products signaling.

Authors:  Damien J Lapar; Vanessa A Hajzus; Yunge Zhao; Christine L Lau; Brent A French; Irving L Kron; Ashish K Sharma; Victor E Laubach
Journal:  Am J Respir Cell Mol Biol       Date:  2011-10-06       Impact factor: 6.914

Review 10.  Advanced glycation end products and diabetic retinopathy.

Authors:  Yashodhara Sharma; Sandeep Saxena; Arvind Mishra; Anita Saxena; Shankar Madhav Natu
Journal:  J Ocul Biol Dis Infor       Date:  2013-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.